» Articles » PMID: 23933946

Usefulness of Endoscopic Submucosal Dissection for Type I Gastric Carcinoid Tumors Compared with Endoscopic Mucosal Resection

Overview
Specialty Gastroenterology
Date 2013 Aug 13
PMID 23933946
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Gastric carcinoid tumors (GCTs) often extends into the submucosa, and are therefore difficult to resect completely by using conventional endoscopic mucosal resection (EMR). Endoscopic submucosal dissection (ESD) allows en bloc resection of submucosal gastrointestinal lesions. Therefore, ESD may be a feasible method for complete resection of GCT. Our purpose is to clarify the usefulness of ESD for treatment of type I GCT.

Methodology: Between 1998 and 2011, EMR or ESD was performed for 13 lesions in 12 patients with type I GCTs. Among the 13 GCTs, 6 were resected using EMR, and 7 were removed using ESD.

Results: All lesions were histologically classified as Grade 1. The depth of invasion was the mucosa for 1 lesion and the submucosa for 12 lesions. The horizontal margins of excision were negative for all lesions; however, the vertical margins were positive in 4 lesions (66.7%) in the EMR group and no lesions (0%) in the ESD group.

Conclusions: The results of this study suggest that ESD for small type I GCT is better to achieve complete resection than conventional EMR. ESD would be an effective technique for the treatment of small type I GCT.

Citing Articles

Predictors of Outcomes in Gastric Neuroendocrine Tumors: A Retrospective Cohort.

Ortigao R, Afonso L, Pimentel-Nunes P, Dinis-Ribeiro M, Libanio D GE Port J Gastroenterol. 2024; 31(4):236-245.

PMID: 39022301 PMC: 11250119. DOI: 10.1159/000530684.


Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.

Huang J, Liu H, Yang D, Xu T, Wang J, Li J Chin Med J (Engl). 2024; 137(6):720-728.

PMID: 38384175 PMC: 10950134. DOI: 10.1097/CM9.0000000000003029.


Management of Gastric Neuroendocrine Tumors: A Review.

Sok C, Ajay P, Tsagkalidis V, Kooby D, Shah M Ann Surg Oncol. 2023; 31(3):1509-1518.

PMID: 38062290 PMC: 10922891. DOI: 10.1245/s10434-023-14712-9.


Role of Advanced Gastrointestinal Endoscopy in the Comprehensive Management of Neuroendocrine Neoplasms.

Gopakumar H, Jahagirdar V, Koyi J, Dahiya D, Goyal H, Sharma N Cancers (Basel). 2023; 15(16).

PMID: 37627203 PMC: 10453187. DOI: 10.3390/cancers15164175.


Endoscopic techniques for gastric neuroendocrine tumors: An update.

Massironi S, Gallo C, Laffusa A, Ciuffini C, Conti C, Barbaro F World J Gastrointest Endosc. 2023; 15(3):103-113.

PMID: 37034968 PMC: 10080559. DOI: 10.4253/wjge.v15.i3.103.